Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford and Bayer HealthCare have entered into a strategic research alliance in the area of gynaecological therapies. The multi-target collaboration focuses on endometriosis and uterine fibroids with the goal of discovering and developing innovative treatment options for these diseases. The alliance is for an initial period of two years, but is open for extension to up to five years.

Endometriosis is a common condition (affecting up to 10% of women in reproductive years), the cause(s) of which are as yet unknown. © Shutterstock
Endometriosis is a common condition (affecting up to 10% of women in reproductive years), the cause(s) of which are as yet unknown.

Development of the INDIGO partnership knowledge exchange strategy

Journal article

Taylor Salisbury T. et al, (2026), SSM - Mental Health, 9, 100602 - 100602

Women with chronic pelvic pain can be stratified using multimodal assessment.

Journal article

Demetriou L. et al, (2026), Pain, 167, 786 - 802

Editorial: Post pregnancy contraception

Journal article

Makins A., (2026), Best Practice & Research Clinical Obstetrics & Gynaecology, 105, 102705 - 102705

Revisiting the promise and pitfalls of mitochondrial replacement therapies

Journal article

Costa-Borges N. and Wells D., (2026), Human Reproduction

Hybrid Maternity Care and Impact on Pregnancy Outcomes: A Systematic Review and Meta-Analysis.

Journal article

D'Alberti E. et al, (2026), Clin Obstet Gynecol, 69, 47 - 53

Load More

Our Research Groups